The American Chamber of Commerce to the EU (AmCham EU) urges the EU Commission to develop a comprehensive and inclusive Strategy for European Life Sciences. This strategy should be built through collaboration with all stakeholders and must aim to enhance innovation, reinforce Europe’s global competitiveness, and ensure long-term sustainability while reducing regulatory burdens.
The EU Commission has unveiled its annual report on Safety Gate, the European Rapid Alert System for dangerous non-food products. The report presents an overview of dangerous products notified in the Safety Gate in 2024. 4137 alerts were notified last year – the highest ever recorded amount of alerts since the launch of the system in 2003.
The agreement marks a significant contribution to strengthening capacities for pandemic prevention, preparedness, and response taking a One Health approach, in full respect of the health policy responsibilities and competences of individual EU Member States.
The agreement reached today on the toy safety regulation reinforces the already stringent safety rules, aligns the obligations of economic operators (both from the EU and third countries) to existing EU legislation, clarifies the rules for the EU digital product passport, and bans or restricts the chemicals products that can be dangerous for children if present in toys.
The European Centre for Disease Prevention and Control (ECDC) is releasing the results of a survey that provides an overview of HIV testing strategies for blood, tissues, and cells donors within the European Union and European Economic Area (EU/EEA).
The EU Council and the European Parliament provisionally agreed on a regulation on preventing the loss of plastic pellets – the industrial raw materials used to make plastic products – into the environment. The new rules will help improve the handling of plastic pellets at all stages of the supply chain, both on land and sea.
Digital health initiatives, including those managed by the European Health and Digital Executive Agency (HaDEA), are central to advancing innovation in healthcare through digital technologies and AI. By supporting intelligent, AI-driven solutions, the EU is contributing to the development of a more accessible, efficient, and equitable healthcare system for everyone.
Carbapenemase-producing bacteria, once primarily confined to hospitals, are now increasingly found in food animals and products across Europe. This alarming trend is highlighted in the European Food Safety Authority’s (EFSA) latest scientific opinion on the presence and spread of carbapenemase-producing Enterobacterales (CPE) in the EU/EFTA food chain.
The EU Commission has launched a consultation on the Action Plan for the cybersecurity of hospitals and healthcare providers. This Action Plan is crucial to protect the healthcare sector from cyber threats and contributes to the successful implementation of the European Health Data Space (EHDS).
An update of the European Cancer Information System (ECIS) displays up-to-date cancer indicators, thanks to the key contribution from European national and regional cancer registries.
The European Centre for Disease Prevention and Control (ECDC) has published a set of recommendations for preparedness planning for public health threats, offering tailored guidance for improving readiness for future health emergencies across European Union/European Economic Area (EU/EEA) countries, at both national and regional levels.
The study published by the European Data Protection Board (EDPB) aims to examine the secondary use of personal data in scientific research—especially in the medical field—by reviewing international agreements, EU and Member State laws, and practices related to purpose limitation, lawfulness, and data subject rights under GDPR transparency exemptions.
A delegation of the European Drugs Agency (EUDA) visits Yerevan to get an update under the EU4Monitoring Drugs II (EU4MD II) project. The visit is organised in close cooperation with the Ministry of Internal Affairs and the Security Council Office of the Republic of Armenia.
For the first time, all the 27 countries of the European Union (EU27) together with Iceland and Norway, have collected and reported data on both sales and use of antimicrobials in animals in their countries. The findings are presented in the first European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet) annual surveillance report.
The EU’s investment will focus on supporting partner countries facing high levels of child malnutrition, particularly in Sub-Saharan Africa. It will target children under five and young pregnant and lactating mothers suffering from severe acute malnutrition. The support will be tailored to address the specific needs of each country, with a strong emphasis on the most vulnerable populations in least developed and fragile settings.
The EU Commission has published a report assessing the work of the Commission’s Health Emergency Preparedness and Response Authority (HERA) since its creation over three years ago. The report highlights HERA’s achievements in strengthening EU-level preparedness and response capacities, as well as taking on new tasks, such as addressing the supply chain aspects of critical medicines shortages.
EU ministers highlighted the growing impact of digital technologies, including social media, on the daily lives of younger generations. Increased stress levels, anxiety, and depression are among the most common consequences of excessive exposure to technology.
From 20 to 26 March 2025, the Horizon 2020 projects EXIMIOUS and EPHOR are organising the Occupational Exposome Week. The projects are part of the European Human Exposome Network (EHEN) and focus on delivering a new way of assessing the human exposome, specifically the occupational exposome.
This call for tenders of the European Health and Digital Executive Agency (HaDEA) aims to speed up the development of a point-of-care diagnostic medical device that can provide antimicrobial susceptibility testing results on bacteria or fungi causing an infection in humans, within one hour or less.
COVID-19 vaccination reduced the risk of developing ‘long COVID’ by approximately 27% in adults fully vaccinated before infection, according to a literature review carried out by the European Centre for Disease Prevention and Control (ECDC).
The EU Commission has approved the acquisition of joint control of Prosper Link International Limited of the British Virgin Islands by Advent International of the US and Mubadala Investment Company of the United Arab Emirates. The transaction relates primarily to the sector of manufacturing and sale of lenses and lens care products.